U.S. Healthtech Stock News

In late June 2026, Northrop Grumman announced a US$312.34 million contract modification to continue producing advanced Surface Electronic Warfare Improvement Program Block Three systems for the U.S. Navy, with work scheduled through August 2029. This award reinforces Northrop Grumman’s role in electronic warfare, a critical capability area that may influence how investors view its long-term defense technology exposure. Next, we will examine how this expanded SEWIP Block Three contract aligns...

Robbins Geller Rudman & Dowd LLP previously announced that class representative Liberty Capital Group and Oppenheimer & Co. Inc. reached a proposed US$70,000,000 settlement of a long-running class action, subject to court approval in the Southern District of New York. This settlement process, including potential court approval and allocation of funds to eligible class members, directly addresses a key legal overhang for Oppenheimer & Co. Inc. We’ll now examine how resolving a US$70,000,000...

Tariffs and freight costs are suddenly front and center again, and that matters directly for the stocks you own. When shipping rates spike and new US tariffs loom over imports from China, Europe and other key partners, some companies see extra revenue, while others face squeezed profit margins and tougher decisions on pricing. This article focuses on that tension, using our Tariff and Freight Disruption Stocks With Direct Supply Chain Exposure screener to pick out 3 stocks exposed to the...

In June 2026, Huntington Ingalls Industries (HII) was added to the Russell 1000 Value-Defensive and Russell 1000 Defensive Indexes, secured a US$417.7 million five-year Navy elevator maintenance contract, opened the new Carrier Refueling Overhaul Workcenter at Newport News, and began fabricating the future USS John F. Lehman (DDG 137). Together, these developments underscore HII’s expanding role across both new-build and long-term sustainment work for the U.S. Navy, while also aligning the...

Sezzle (SEZL) has been dropped from several Russell value benchmarks, including the Russell 2000 Value, even as Oppenheimer highlights the company’s growth profile, product development, and exposure to discretionary spending trends. See our latest analysis for Sezzle. At a share price of $175.18, Sezzle has seen strong recent momentum, with a 30 day share price return of 42.96% and a 90 day share price return of 174.75%. The 1 year total shareholder return of 1.67% suggests short term...

On 27 June 2026, Encore Capital Group, Inc. was added to both the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index, shortly after its CIO presented at the Confidential Computing Summit in San Francisco. These index additions can increase visibility and passive fund interest in Encore, potentially reinforcing its positioning as a more defensively oriented consumer finance name. Next, we’ll examine how Encore’s inclusion in the Russell 2000 defensive indices interacts...

WeRide (WRD) is in focus after announcing a three way partnership with Geely Farizon and Kwoon Chung Bus Holdings to co develop purpose built right hand drive Robotaxis, with commercial deployment starting in Hong Kong. See our latest analysis for WeRide. The Robotaxi partnership comes as WeRide's share price has declined 26.9% over the past 30 days and 39.2% year to date, with a 1 year total shareholder return down 28.8%. As a result, the announcement appears to be arriving against weak...

Cisco Systems (CSCO) is back in focus after an analyst upgrade tied to an improved earnings outlook, stronger guidance for AI infrastructure revenue, and new alliances in enterprise AI and quantum secure networking. See our latest analysis for Cisco Systems. Despite a slight pullback in the last week and month, with the 7 day share price return down 2.27% and the 30 day share price return down 3.56% to US$117.01, Cisco Systems has seen strong momentum over longer periods, including a 90 day...

Quantum computing stocks sit at the crossroads of high end research and real world problem solving at a time when global data, supply chains and pricing pressures are all in focus for investors. With inflation trends mixed, interest rates still central to markets, and growth signals varying by region, some readers are looking beyond traditional sectors to themes that are driven by long term science and specialised expertise rather than short term demand swings. This Quantum Computing Stocks...

Kyndryl Holdings (KD) is in focus after announcing expanded sovereignty solutioning with Microsoft and a deeper Amazon Web Services agreement for agentic AI, moves that reshape how the company positions its cloud and compliance services. See our latest analysis for Kyndryl Holdings. The latest Microsoft and Amazon Web Services agreements arrive as Kyndryl Holdings works against weak recent performance, with the share price up 6.10% over one day and 8.11% over seven days, but down sharply year...

International Flavors & Fragrances recently launched SENSORA™, a patent-pending, light-activated pro-fragrance technology designed to deliver evolving, long-lasting scent experiences across home, fabric, and personal care products, with its first application Floral Fusion targeted at liquid detergents. This technology gives perfumers finer control over how fragrances unfold for days after activation, potentially strengthening IFF’s position in higher-value, performance-focused scent...

Sylvamo (SLVM) was removed from several Russell growth benchmarks on 27 June, a technical index change that can influence how index-linked funds and some active managers size their positions in the stock. See our latest analysis for Sylvamo. That index removal comes after a period of softer momentum for Sylvamo, with the share price down 5.95% over the past week and 21.62% year to date. The 3 year total shareholder return is modestly positive at 2.20%, suggesting recent selling pressure is...

In late June 2026, LifeStance Health Group, Inc. was removed from several Russell indices, including the Russell 2000 Growth-Defensive and multiple value benchmarks, following the latest reconstitution. This broad index exit is significant because it can alter how passive funds and benchmark-aware investors gain or maintain exposure to the stock. We’ll now explore how LifeStance Health’s removal from key Russell indices shapes the company’s investment narrative and future investor...

With the Federal Reserve now signaling at least one rate increase in 2026, higher borrowing costs and pressure on valuation multiples are back in focus. For income investors, that can put more attention on stocks that already pay higher dividends and carry moderate risk profiles, rather than relying on price gains alone. This article pulls from a High Dividend Yield Stocks screener built around the Fed’s latest stance and related inflation worries, and will walk through 3 stocks that appear...

In late June 2026, Snowflake Inc. held its annual general meeting where shareholders approved a non-binding proposal supporting majority voting for director elections, while the company was simultaneously reclassified into the Russell Midcap and Russell Midcap Growth benchmarks. Alongside these governance and index changes, Marketplacer Pty Ltd. and Unlimitail announced deeper collaborations that embed Snowflake’s AI Data Cloud at the core of marketplace and retail media data infrastructure...

AI partnership with Lilly TuneLab puts Charles River Laboratories International stock in focus Charles River Laboratories International (CRL) has drawn fresh attention after announcing a collaboration with Lilly TuneLab, an AI and machine learning drug discovery platform created by Eli Lilly and Company. The agreement positions Charles River to supply nonclinical testing services to TuneLab participants, standardizing protocols across the platform and supporting AI models that aim to...

In the recent quarter, gold prices experienced their sharpest selloff in 13 years, drawing attention to DRDGOLD Limited, Newmont Corporation and Barrick Mining Corporation as potential beneficiaries of the volatility. For DRDGOLD, the focus has fallen on its Vision 2028 expansion plan and debt-free balance sheet, which some investors see as strengthening its longer-term appeal despite near-term price pressure on gold. We’ll now explore how DRDGOLD’s Vision 2028 growth plan and solid...

Founder led companies can be a useful way to focus on leaders who are deeply tied to the future of their business at a time when global signals are mixed, inflation trends differ by region, and central banks are weighing their next moves. While manufacturing, trade, housing, and consumer confidence all send a mixed but resilient picture, this screener filters for founders who still have skin in the game and a long term mindset. In this article, there is a closer look at 3 stocks from the...

China’s decision to commit $295b to data center and AI infrastructure has put VNET Group (NasdaqGS:VNET) in focus, with the stock reacting to expectations for higher demand across its hosting and cloud services. See our latest analysis for VNET Group. The recent jump in VNET Group’s share price, including a 1-day share price return of 9.58% and 7-day share price return of 8.10%, comes after China’s $295b AI and data center plan refocused attention on high beta infrastructure stocks. This is...

Global markets are sending mixed signals, with manufacturing activity, inflation trends, and bond yields pulling in different directions across regions. In this kind of patchwork, investors often look for themes tied to real, physical demand rather than short term sentiment swings. The AI Infrastructure Stocks screener focuses on companies that supply the data centers, power, and cooling that AI systems rely on, where demand is tied to hardware build out rather than just software hype. In...

Recent Performance Snapshot for Personalis Stock Personalis (PSNL) has drawn fresh attention after a stretch of strong share price performance, with the stock up over the past week, month, past 3 months and year, alongside positive annual revenue and net income growth figures. At a last close of $13.79, Personalis carries a market value of about $1.4b, supported by reported revenue of $64.515 million and a net loss of $95.552 million, which keeps profitability in focus for investors. See our...

Roper Technologies (ROP) has just shifted index tiers, moving out of the Russell Top 200 indices and into the Russell Midcap and Russell Midcap Value benchmarks, a change that can influence trading flows and liquidity. See our latest analysis for Roper Technologies. That index reshuffle comes as Roper Technologies trades at US$354.68, with a 1-day share price return of 4.81% and a 7-day share price return of 6.96%, even though the year-to-date share price return is down 18.38% and the 1-year...

Unicycive Therapeutics (UNCY) is back in focus after the US Food and Drug Administration issued a Complete Response Letter on its resubmitted New Drug Application for oxylanthanum carbonate, keeping approval on hold over third party manufacturing issues. See our latest analysis for Unicycive Therapeutics. The FDA letter and the recent expansion of Unicycive Therapeutics' at-the-market program have coincided with sharp share price swings, including a 12.58% 1-day share price return, but 7-day...

EPAM Systems (EPAM) is facing an unusual mix of signals, with its recent removal from the Russell 1000 Defensive Indexes coinciding with fresh recognition as Databricks’ 2026 AI Partner of the Year. See our latest analysis for EPAM Systems. Those mixed signals are landing on a stock that has been under pressure for some time. EPAM Systems’ share price is down 57.5% year to date and its 5 year total shareholder return has declined 83.8%. At the same time, short term share price momentum has...